CTSA Funding Guidelines

To meet the goal of funding a total of 60 CTSAs in 2012 with a budget of $500 million per year, NCRR developed funding guidelines that were applied to awards made in 2007 and 2008 and will be continued indefinitely. In general, the guidelines are as follows:

• New funds included in the CTSA grant will provide an increase of 35 - 45 percent over pre-existing NIH clinical research resources (i.e., NCRR K30, M01, and Roadmap T32 and K12), up to a ceiling of $6 million total in new funding.
• Certain successful applications may have low levels of the pre-existing NIH clinical research resources. To ensure that these CTSAs are successful, NCRR will support a minimum total award of $4 million, or $1.5 million in new funding, whichever is the higher amount.

NCRR will work closely with the current and new awardees to promote the sharing of resources through the Consortium and to modify the scope of individual awards as necessary.

The CTSA institutions, by working as a consortium both regionally and nationally and in cooperation with the NIH, can build on their strengths and expertise to transform clinical and translational research across the Nation.

CTSA Funding Guidelines: Questions and Answers

• CTSA Funding Guidelines: Questions and Answers - September 18, 2007

Contact Information

For further information about the Clinical and Translational Science Awards and the CTSA Consortium, please contact:

Anthony R. Hayward, M.D., Ph.D.
Director
Division of Clinical Research Resources
National Center for Research Resources
National Institutes of Health
One Democracy Plaza, Room 906
6701 Democracy Boulevard, MSC 4874
Bethesda, Maryland 20892-4874 (20817 for express mail)
Telephone: 301-435-0790
Fax: 301-480-3661
HaywardA@mail.nih.gov